Benefix Kit
NDC 58394-635
Product Information
Benefix (coagulation factor ix (recombinant)) is a BLA-approved product labeled by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a kit. This product entry covers the primary NDC 58394-635 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 58394-635?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BeneFIX (NDC 58394-135)
- COAGULATION FACTOR IX RECOMBINANT HUMAN (UNII: 382L14738L)
- COAGULATION FACTOR IX RECOMBINANT HUMAN (UNII: 382L14738L) (Active Moiety)
- Alcohol
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- ISOPROPYL ALCOHOL (UNII: ND2M416302) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BeneFIX (NDC 58394-135)
- HISTIDINE (UNII: 4QD397987E)
- GLYCINE (UNII: TE7660XO1C)
- SUCROSE (UNII: C151H8M554)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- Diluent (NDC 58394-041)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- WATER (UNII: 059QF0KO0R)
- Alcohol
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1666311 - coagulation factor IX (recombinant human) 1 UNT Injection
- RxCUI: 1666311 - nonacog alfa 1 UNT Injection
- RxCUI: 1666317 - BeneFIX 1 UNT Injection
- RxCUI: 1666317 - nonacog alfa 1 UNT Injection [BeneFIX]
- RxCUI: 1666317 - BeneFIX (coagulation factor IX (recombinant human)) 1 UNT Injection
* Please review the full disclaimer at the bottom of this page.